| 1 |
Girn M, Rosas FE, Daws RE, Gallen CL, Gazzaley A, Carhart-Harris RL. A complex systems perspective on psychedelic brain action. Trends Cogn Sci 2023:S1364-6613(23)00021-9. [PMID: 36740518 DOI: 10.1016/j.tics.2023.01.003] [Reference Citation Analysis]
|
| 2 |
Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, Chow WL, Gray JA, Olson DE. 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines. ACS Chem Neurosci 2023;14:351-8. [PMID: 36630260 DOI: 10.1021/acschemneuro.2c00718] [Reference Citation Analysis]
|
| 3 |
Yu ZP, Li Q, Wu ZX, Tang ZH, Zhang XQ, Wang ZC, Xu P, Shen HW. The high frequency oscillation in orbitofrontal cortex is susceptible to phenethylamine psychedelic 25C-NBOMe in male rats. Neuropharmacology 2023;:109452. [PMID: 36724866 DOI: 10.1016/j.neuropharm.2023.109452] [Reference Citation Analysis]
|
| 4 |
Pacheco AT, Olson RJ, Garza G, Moghaddam B. Acute psilocybin enhances cognitive flexibility in rats. bioRxiv 2023:2023. [PMID: 36712091 DOI: 10.1101/2023.01.09.523291] [Reference Citation Analysis]
|
| 5 |
Qu Y, Chang L, Ma L, Wan X, Hashimoto K. Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice. Pharmacol Biochem Behav 2023;222:173500. [PMID: 36476377 DOI: 10.1016/j.pbb.2022.173500] [Reference Citation Analysis]
|
| 6 |
Meccia J, Lopez J, Bagot RC. Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms. Psychopharmacology (Berl) 2023;240:27-40. [PMID: 36564671 DOI: 10.1007/s00213-022-06297-0] [Reference Citation Analysis]
|
| 7 |
Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice.. [DOI: 10.1101/2022.11.03.515044] [Reference Citation Analysis]
|
